Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy (Q35927368)
Jump to navigation
Jump to search
scientific article published in April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy |
scientific article published in April 2012 |
Statements
1 reference
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy (English)
1 reference
S Bellone
1 reference
D Roque
1 reference
E Cocco
1 reference
S Gasparrini
1 reference
I Bortolomai
1 reference
N Buza
1 reference
M Abu-Khalaf
1 reference
D-A Silasi
1 reference
E Ratner
1 reference
M Azodi
1 reference
P E Schwartz
1 reference
T J Rutherford
1 reference
S Pecorelli
1 reference
A D Santin
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference